Holen Sie sich die Stockscreener-App
3.71
23.66%
-1.15
Handel nachbörslich:
3.50
-0.21
-5.66%
Schlusskurs vom Vortag:
$4.86
Offen:
$4.6
24-Stunden-Volumen:
454.08K
Relative Volume:
0.60
Marktkapitalisierung:
$3.35M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.22M
KGV:
-0.4983
EPS:
-7.4459
Netto-Cashflow:
$-4.78M
1W Leistung:
+53.94%
1M Leistung:
+48.70%
6M Leistung:
+37.92%
1J Leistung:
-15.10%
1-Tages-Spanne:
$3.70
$4.696
1-Wochen-Bereich:
$3.01
$5.52
52-Wochen-Spanne:
$1.84
$5.52
Synaptogenix Inc Stock (SNPX) Company Profile
Firmenname
Synaptogenix Inc
Sektor
Branche
Telefon
(973) 242-0005
Adresse
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK
Vergleichen Sie SNPX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SNPX
Synaptogenix Inc
|
3.71 | 3.35M | 0 | -8.22M | -4.78M | -7.4459 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.45 | 115.69B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
529.24 | 53.25B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
307.99 | 39.22B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.89 | 35.78B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
269.63 | 27.68B | 3.81B | -644.79M | -669.77M | -6.24 |
Synaptogenix Inc Aktie (SNPX) Neueste Nachrichten
Pre-market Movers: HCTI, KLTO, INTS, HSDT... - RTTNews
TAO Is Next for Corporate Treasury, Nasdaq Giants Fuel Bittensor’s 10% Rally - Coinspeaker
Bittensor (TAO) Becomes the Next Pick in the Wave of Public Crypto Treasuries - BeInCrypto
Health Care Sector Sees Mixed Results And Strategic Moves - Finimize
Synaptogenix pumps $100m into artificial intelligence token - Mugglehead Magazine
Klotho Neurosciences Sees Massive Jump After Promising Gene Study - Finimize
Synaptogenix (SNPX) Unveils AI-Focused Cryptocurrency Strategy | - GuruFocus
Synaptogenix, Inc. announced that it expects to receive $5.5 million in funding - marketscreener.com
Synaptogenix Unveils TAO-Focused Crypto Treasury Plan - Live Bitcoin News
Synaptogenix Appoints James Altucher to Lead Digital Asset Treasury Strategy - citybiz
Synaptogenix Says On June 8, Alan Tuchman Resigned As CEO And Director Of Co - marketscreener.com
Synaptogenix Launch Of Differentiated Cryptocurrency Treasury Strategy Focused Exclusively On AI Crypto Token 'TAO' - marketscreener.com
Synaptogenix Stock Soars on Bold AI Crypto Bet - RagingBull
Synaptogenix Announces $5.5M Securities Purchase Agreement - TipRanks
Synaptogenix Appoints Crypto Expert to Lead Digital Asset Treasury Strategy Focused Exclusively on Top-Valued AI Token | SNPX Stock News - GuruFocus
First Pure-Play AI Crypto Stock: Synaptogenix Commits $100M to Leading AI Token TAO, Appoints Crypto Expert - Stock Titan
Full Stock Market News from 2025-06-06 - Stock Titan
Synaptogenix, Inc. (NASDAQ:SNPX) Short Interest Update - Defense World
Synaptogenix (NASDAQ:SNPX) Trading 1.5% Higher – Here’s What Happened - Defense World
Full Stock Market News from 2025-05-27 - Stock Titan
Full Stock Market News from 2025-05-22 - Stock Titan
SNPXSynaptogenix Latest Stock News & Market Updates - Stock Titan
Geode Capital Management LLC Takes $39,000 Position in Synaptogenix, Inc. (NASDAQ:SNPX) - Defense World
Synaptogenix stock plunges to 52-week low of $2.14 By Investing.com - Investing.com Canada
Synaptogenix stock plunges to 52-week low of $2.14 - Investing.com Australia
Synaptogenix Inc. (SNPX) reports earnings - qz.com
Will Synaptogenix Make A Mark In Synaptic Regeneration? - RTTNews
Synaptogenix stock hits 52-week low at $2.15 amid market challenges - Investing.com Australia
Synaptogenix stock hits 52-week low at $2.15 amid market challenges By Investing.com - Investing.com South Africa
Ensysce Biosciences Stock Price, Quotes and Forecasts | NASDAQ:ENSC - Benzinga
Synaptogenix (NASDAQ:SNPX) Trading Down 0.3% – Here’s Why - Defense World
Sonnet BioTherapeutics Stock Price, Quotes and Forecasts - Benzinga
Mustang Bio Stock Price, Quotes and Forecasts | NASDAQ:MBIO - Benzinga
Aptevo Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:APVO - Benzinga
ZyVersa Therapeutics (NASDAQ:ZVSA) Stock Quotes, Forecast and News Summary - Benzinga
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.18% - MSN
Finance Watch: As Cash Dwindles, Biotechs Cut Costs, Sell Assets, Merge, Assess Options - News & Insights
Synaptogenix Forms Special Committee to Explore Value Creation Opportunities Utilizing Balance Sheet Strength - Marketscreener.com
Synaptogenix (SNPX) Extends CEO’s Employment and Forms Special Committee to Explore Strategic Opportunities - Defense World
Synaptogenix forms committee to explore strategic opportunities - Investing.com
Synaptogenix forms committee to explore strategic opportunities By Investing.com - Investing.com South Africa
Synaptogenix Restructures Leadership Amid Strategic Refocus - TipRanks
Synaptogenix Forms Special Committee to Explore Strategic Options with $19.6M Cash Runway - StockTitan
Informatica Leads Gartner Magic Quadrant for Data Integration Tools for 19th Straight Year - Stock Titan
Synaptogenix shareholders approve key proposals at annual meeting By Investing.com - Investing.com Canada
Synaptogenix shareholders approve key proposals at annual meeting - Investing.com
Synaptogenix appoints new auditor as Morison Cogen exits - Investing.com
Finanzdaten der Synaptogenix Inc-Aktie (SNPX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.91%
1.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):